Alanna Nattis, DO
Ophthalmology · Westbury, NYNPI 1558700542
Payments from drug & device makers
Across 271 payments — averaging $2120.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon Research LLC$262K
- Ocular Therapeutix, Inc.$131K
- Glaukos Corporation$73K
- Topcon Healthcare, Inc.$47K
- Bausch Health US, LLC$23K
- Alcon$17K
- plus $21K from 20 others
Across 2 payments — averaging $11,250 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alcon Research LLC$23K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon Research LLC | 24 | $261,907 |
| Ocular Therapeutix, Inc. | 14 | $131,460 |
| Glaukos Corporation | 54 | $72,595 |
| Topcon Healthcare, Inc. | 3 | $47,071 |
| Bausch Health US, LLC | 2 | $23,281 |
| Alcon | 32 | $17,189 |
| Novartis | 19 | $10,641 |
| Tarsus Pharmaceuticals, Inc. | 6 | $4,125 |
| Sight Sciences, Inc. | 9 | $3,106 |
| AbbVie(2 entities) | 34 | $745 |
| Biotissue Holdings Inc. | 13 | $412 |
| Eyevance Pharmaceuticals LLC | 5 | $389 |
| Harrow Eye, LLC | 7 | $307 |
| Dompe US, Inc. | 8 | $264 |
| Oyster Point Pharma, Inc. | 10 | $258 |
| Bausch & Lomb Americas Inc. | 5 | $216 |
| Kala Pharmaceuticals, Inc. | 4 | $182 |
| Carl Zeiss Meditec, Inc. | 1 | $142 |
| Shire North American Group Inc | 4 | $96 |
| Mallinckrodt Hospital Products Inc. | 5 | $93 |
| Sun Pharmaceutical Industries Inc. | 4 | $70 |
| Apellis Pharmaceuticals, Inc. | 2 | $63 |
| Amgen | 2 | $52 |
| Aerie Pharmaceuticals, Inc. | 1 | $35 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $33 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $20 |
How this compares
$574,752 in reported general payments places this provider in the 95th percentile of 1,587 ophthalmology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Westbury
- Douglas JabsNew York$24.3M
- David RubaltelliBrooklyn$8.9M
- Philip FerroneGreat Neck$5.8M
- Eric DonnenfeldGarden City$2.6M
- Nathan RadcliffeNew York$2.4M
- Glenn StollerRockville Centre$2.1M
- Richard SpaideNew York$1.7M
- Paul HartmanRochester$1.6M
- Jason SlakterNew York$1.2M
- David ChuNew York$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.